Scientific publications
Found 9 results

Sort by: Author [ Keyword  (Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
virtual screening
Validation study
Zaliani A, Boda K, Seidel T, et al. "Second-generation de novo design: a view from a medicinal chemist perspective." J. Comput. Aided Mol. Des.. 2009;23(8):593-602. Abstract

SYLVIA

TOXICITY
THRESHOLD OF TOXICOLOGICAL CONCERN (TTC)
Synthetic accessibility
Zaliani A, Boda K, Seidel T, et al. "Second-generation de novo design: a view from a medicinal chemist perspective." J. Comput. Aided Mol. Des.. 2009;23(8):593-602. Abstract

SYLVIA

SYLVIA
Zaliani A, Boda K, Seidel T, et al. "Second-generation de novo design: a view from a medicinal chemist perspective." J. Comput. Aided Mol. Des.. 2009;23(8):593-602. Abstract

SYLVIA

Structure–property–activity relationship model
Structure-based de novo design
Zaliani A, Boda K, Seidel T, et al. "Second-generation de novo design: a view from a medicinal chemist perspective." J. Comput. Aided Mol. Des.. 2009;23(8):593-602. Abstract

SYLVIA

Size-intensive descriptors
similarity searching
RISK ASSESSMENT
retrospective screening
Partial Least Squares (PLS)
NovoBench
Zaliani A, Boda K, Seidel T, et al. "Second-generation de novo design: a view from a medicinal chemist perspective." J. Comput. Aided Mol. Des.. 2009;23(8):593-602. Abstract

SYLVIA

Molecular modeling
Molecular Electrostatic Potential (MEP)
Lipid rafts
ligand-bound conformation
Schwab CH. "Conformations and 3D pharmacophore searching." Drug Discovery Today: Technologies. 2010;7(4):e245-e253. Abstract

CORINA, ROTATE

GPCR
FragView
Zaliani A, Boda K, Seidel T, et al. "Second-generation de novo design: a view from a medicinal chemist perspective." J. Comput. Aided Mol. Des.. 2009;23(8):593-602. Abstract

SYLVIA

Fragment space
Zaliani A, Boda K, Seidel T, et al. "Second-generation de novo design: a view from a medicinal chemist perspective." J. Comput. Aided Mol. Des.. 2009;23(8):593-602. Abstract

SYLVIA

FlexNovo
Zaliani A, Boda K, Seidel T, et al. "Second-generation de novo design: a view from a medicinal chemist perspective." J. Comput. Aided Mol. Des.. 2009;23(8):593-602. Abstract

SYLVIA

Feature Trees
Zaliani A, Boda K, Seidel T, et al. "Second-generation de novo design: a view from a medicinal chemist perspective." J. Comput. Aided Mol. Des.. 2009;23(8):593-602. Abstract

SYLVIA

eTOX